This Pharma Stock Is Soaring 90% 📈

Good morning. It’s August 8th, and we’re going to look at Warner Bros. Discovery and Bumble's disappointing results, as well as a tiny pharma stock that’s rallying by 90% in premarket trade.

Previous Close 📈

Stocks fell despite an early rally on Wednesday as investors continue to worry about the possibility of a recession. All three indices ended up in the red.

Futures

Stock futures are stable today after several days of ups and downs.

What to Watch

Pharmaceutical firm Eli Lilly and fast food giant Restaurant Brands International will share their earnings reports before the opening bell today.

Keep an eye out for the Initial Jobless Claims data, which will be released at 8:30 a.m.

Later in the day, Richmond Fed President Tom Barkin will give a speech at 3:00 p.m.

New "Automated Options" Allow Folks to HIJACK Stocks

Thanks to a little known automatic pricing anomaly within a handful of options, an under-the-radar trader from Pittsburgh has nailed down what could be 50% ROI per week...

…completely hands free. As long as a stock makes a 1%+ move within that week, his special type of trade is set to close out automatically.

Click Here to Watch Him Place the Next Trade + Claim a $1,250 Surprise

Media & Entertainment

Warner Bros. Discovery Stock Plummets Following Major Write-Down

Warner Bros. Discovery is facing a dramatic 11% drop in premarket trading today following yesterday's disappointing second-quarter earnings announcement.

The company revealed a substantial $9.1 billion impairment charge related to its television networks unit. Additionally, its merger-related costs amounted to $2.1 billion, leading to a total financial hit of $11.2 billion for the last quarter.

CEO David Zaslav highlighted the challenging market conditions for legacy media companies over the past two years, using it to justify the impairment in order to align the company's valuation with future expectations.

CFO Gunnar Wiedenfels noted that several factors, including a weak U.S. ad market and uncertainties in affiliate and sports rights renewals, also influenced the financial adjustments.

Despite adding nearly 4 million subscribers to its streaming service, the company's linear TV unit continued to underperform.

Revenue for the quarter was $9.7 billion, falling short of the $10.12 billion expected and marking a 6% decline from the previous year. The adjusted loss per share was $4.07, significantly worse than the $0.51 loss from the previous year and below the forecasted $0.21 loss due to the impairment charge.

Technology

Bumble Stock Plummets as Revenue Forecast Cut Sparks Investor Concerns

Bumble’s shares are plummeting by 40% in premarket trading after the dating app revised its annual revenue growth forecast downward yesterday, causing worries about its turnaround strategy.

The company now anticipates its full-year revenue to increase by just 1% to 2%, significantly lower than its previous estimate of 8% to 11%.

Consequently, Bumble has decided to postpone some of its monetization initiatives, including the rollout of its Premium Plus subscription service, initially planned for later this year.

The revised forecast has raised doubts about user uptake after the recent relaunch of Bumble’s primary app and the refresh of its Premium Plus offering amid a sluggish user spending environment.

In the second quarter, Bumble's average revenue per paying user dropped to $21.37 from $23.23 in the same period last year.

Fast Food

Restaurant Brands International Outperforms Q2 Revenue Forecasts

Restaurant Brands International, the parent company of Burger King and Tim Hortons, surpassed Wall Street expectations for second-quarter revenue in its earnings report.

This is driven by steady demand at its fast-food outlets despite a broader slowdown in the U.S. fast-food industry.

Fast-food chains have been aggressively offering discounts and promotions to attract customers amid persistent inflation and high borrowing costs that discourage dining out.

Burger King has particularly benefited from the reintroduction of its $5 value meal, preceding a similar move by its competitor, McDonald's.

Additionally, investments in store upgrades, equipment, and advertising, as part of a comprehensive turnaround plan, have contributed to its success.

Average foot traffic per Burger King location increased by 4.3% in the quarter, a significant rise compared to the 1% increase seen a year earlier.

For the second quarter, the firm reported revenue of $2.08 billion, outperforming analysts' average estimate of $2.02 billion.

An Extremely Rare Market Window is About to Open

An extremely rare window in the markets is about to open, one that's been seen only 13 times since 1920. Wall Street legend Whitney Tilson says this unique opportunity could close much sooner than anyone realizes.

Missing it means losing the chance for potential triple- or quadruple-digit gains in mere months.

Watch an exclusive interview with Whitney Tilson and another top analyst as they reveal how to prepare for this event and share their No. 1 stock recommendation, which could soar 500%-plus.

Click Here to Watch the Exclusive Interview for Free

Conduit Pharmaceuticals Inc. [CDT] - Last Close: $0.165

Conduit Pharmaceuticals' stock is rallying by more than 90% in premarket trade today.

The firm announced today that it is getting $2.65 million in funding through a financing agreement with Nirland Limited.

This agreement involves issuing 12.5 million shares of common stock and carries a 12% annual interest rate.

Additionally, Conduit has also received a significant patent from IP Australia for a key drug, AZD1656, which provides up to 20 years of protection.

ANEW Medical, Inc. [WENA] - Last Close: $1.09

ANEW Medical's stock is up by 45% so far in premarket trade.

The company announced today that it has received important patents in major Asian markets, including China, Hong Kong, and Shanghai.

These patents will protect its innovative genetic therapy for treating Alzheimer's Disease (AD) and other neurodegenerative diseases like ALS and Parkinson's.

This means ANEW will have exclusive rights to use and develop these therapies in these regions.

Harrow, Inc. [HROW] - Last Close: $21.98

Harrow's stock is rallying by nearly 35% in premarket trade.

The company reported strong financial results for the second quarter of 2024 yesterday.

It achieved record revenue of $48.9 million and adjusted EBITDA of $8.8 million. While the company had a net loss of $6.5 million, its cash reserves are strong at $71 million.

Key highlights include a significant increase in demand for their eye care products. IHEEZO's customer unit demand nearly doubled, and prescriptions for VEVYE more than tripled compared to the previous quarter.

Additionally, its anterior segment revenue grew by over 40%.

40 Years Of Investing Secrets - 1 Free Guide

Veteran investor Tom Busby's free guide, the Little Black Book, could do two things:

First, empower everyday traders to make potentially more profitable choices.

Second, it could make the execs on Wall Street absolutely furious.

Find out why today!

Click Here to Get Your Free Copy of Busby's Little Black Book, Now!

Everything Else

• Indian stocks outperform their U.S. counterparts, fueled by rate cut speculation.

• Siemens sees a profit boost but warns of a cautious investment climate.

• SMIC outperforms expectations despite a significant profit decline.

• U.S. travel and leisure companies feel the pinch from reduced consumer spending.

• Ukraine's border raid prompts mass evacuation and an emergency declaration in Russia.

• Embraer saw significant profit growth in Q2 and reconfirmed 2024 outlook.

• Blink Charging reported lower-than-expected Q2 sales and earnings.

• Eli Lilly's weight-loss drug sales propel a stock surge.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.